down arrow

Genscript Biotech Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG3825B1059
HKD
13.50
0.14 (1.05%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Net Sales
6,572.62
4,899.52
3,972.40
3,031.40
2,141.78
1,810.61
1,189.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,572.62
4,899.52
3,972.40
3,031.40
2,141.78
1,810.61
1,189.57
Raw Material Cost
3,366.26
2,518.40
1,613.47
1,046.69
743.30
580.45
377.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
3,996.12
3,412.26
2,588.13
1,735.46
1,188.54
726.73
384.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
215.37
103.90
18.48
42.13
6.12
0.41
0.00
Selling and Distribution Expenses
2,871.91
2,725.53
2,282.29
1,533.17
984.59
617.19
305.92
Other Expenses
-82.29
-46.15
17.92
26.53
26.29
-14.66
-24.40
Total Expenditure (Excl Depreciation)
9,626.75
8,298.58
6,681.55
4,622.80
3,185.41
1,778.21
823.87
Operating Profit (PBDIT) excl Other Income
-3054.1000000000004
-3399.1000000000004
-2709.2000000000003
-1591.3999999999999
-1043.6
32.400000000000006
365.7
Other Income
253.78
140.90
-50.97
97.11
153.22
137.35
-73.45
Operating Profit (PBDIT)
-2,220.65
-2,755.77
-2,388.75
-1,239.15
-728.67
269.31
345.37
Interest
215.37
103.90
18.48
42.13
6.12
0.41
0.00
Exceptional Items
267.93
-18.07
-1,079.63
-645.35
8.16
10.15
8.24
Gross Profit (PBDT)
3,206.37
2,381.12
2,358.93
1,984.70
1,398.48
1,230.16
812.32
Depreciation
579.70
502.39
371.38
255.13
161.73
99.57
53.12
Profit Before Tax
-2,747.79
-3,380.13
-3,858.24
-2,181.77
-888.37
179.49
300.49
Tax
32.43
-29.12
35.59
-3.70
29.98
15.21
89.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-747.48
-1,776.35
-2,703.90
-1,589.55
-759.32
166.28
203.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-747.48
-1,776.35
-2,703.90
-1,589.55
-759.32
166.28
203.57
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2,032.74
-1,574.87
-1,189.94
-593.16
-161.44
-3.58
6.87
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-2,780.22
-3,351.22
-3,893.83
-2,182.72
-920.76
162.70
210.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.0
0.0
Reserves
10,862.31
7,887.22
6,858.80
6,991.69
2,982.73
3,747.63
1,702.68
Earnings per share (EPS)
-0.35
-0.85
-1.33
-0.84
-0.41
0.09
0.12
Diluted Earnings per share
-0.35
-0.85
-1.33
-0.84
-0.41
0.09
0.12
Operating Profit Margin (Excl OI)
-46.47%
-69.38%
-68.2%
-52.5%
-48.73%
1.79%
30.74%
Gross Profit Margin
-32.99%
-58.74%
-87.78%
-63.56%
-33.93%
15.41%
29.73%
PAT Margin
-11.37%
-36.26%
-68.07%
-52.44%
-35.45%
9.18%
17.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is 34.15% vs 23.34% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is 17.04% vs 13.93% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 14.58% vs -23.91% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 107.31% vs 461.62% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has improved from Dec 2022

Compare Annual Results Of Genscript Biotech Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
6,572.62
31,452.52
-24,879.90
-79.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,572.62
31,452.52
-24,879.90
-79.10%
Raw Material Cost
3,366.26
9,444.18
-6,077.92
-64.36%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
3,996.12
4,744.41
-748.29
-15.77%
Power Cost
0
0
0.00
Manufacturing Expenses
215.37
47.35
168.02
354.85%
Selling and Distribution Expenses
2,871.91
10,576.50
-7,704.59
-72.85%
Other Expenses
-82.29
83.61
-165.90
-198.42%
Total Expenditure (Excl Depreciation)
9,626.75
25,648.52
-16,021.77
-62.47%
Operating Profit (PBDIT) excl Other Income
-3,054.13
5,804.01
-8,858.14
-152.62%
Other Income
253.78
502.20
-248.42
-49.47%
Operating Profit (PBDIT)
-2,220.65
7,754.89
-9,975.54
-128.64%
Interest
215.37
47.35
168.02
354.85%
Exceptional Items
267.93
-113.26
381.19
336.56%
Gross Profit (PBDT)
3,206.37
22,008.35
-18,801.98
-85.43%
Depreciation
579.70
1,448.68
-868.98
-59.98%
Profit Before Tax
-2,747.79
6,145.60
-8,893.39
-144.71%
Tax
32.43
1,344.33
-1,311.90
-97.59%
Provisions and contingencies
0
0
0.00
Profit After Tax
-747.48
4,692.56
-5,440.04
-115.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-747.48
4,692.56
-5,440.04
-115.93%
Share in Profit of Associates
0
0
0.00
Minority Interest
-2,032.74
11.70
-2,044.44
-17,473.85%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-2,780.22
4,704.26
-7,484.48
-159.10%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
10,862.31
34,336.48
-23,474.17
-68.37%
Earnings per share (EPS)
-0.35
0.40
-0.75
-187.50%
Diluted Earnings per share
-0.35
0.40
-0.75
-187.50%
Operating Profit Margin (Excl OI)
-46.47%
18.45%
0.00
-64.92%
Gross Profit Margin
-32.99%
24.15%
0.00
-57.14%
PAT Margin
-11.37%
14.92%
0.00
-26.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 657.26 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 34.15% vs 23.34% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit -278.02 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 17.04% vs 13.93% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -247.44 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 14.58% vs -23.91% in Dec 2022

Annual - Interest
Interest 21.54 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 107.31% vs 461.62% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -46.47%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has improved from Dec 2022

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."